IBRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Immunitybio Inc (IBRX).


$1.78B Market Cap.

As of 03/04/2025 5:00 PM ET (MRY) • Disclaimer

IBRX Market Cap. (MRY)


IBRX Shares Outstanding (MRY)


IBRX Assets (MRY)


Total Assets

$382.93M

Total Liabilities

$871.06M

Total Investments

$13.51M

IBRX Income (MRY)


Revenue

$14.74M

Net Income

-$413.56M

Operating Expense

$358.93M

IBRX Cash Flow (MRY)


CF Operations

-$391.24M

CF Investing

-$12.25M

CF Financing

$281.63M

IBRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

IBRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$382,933,000 (-24.09%)

$504,452,000 (39.21%)

$362,356,000 (-22.72%)

$468,910,000 (111.81%)

Assets Current

$184,586,000 (-37.23%)

$294,084,000 (109.20%)

$140,577,000 (-57.95%)

$334,347,000 (199.29%)

Assets Non-Current

$198,347,000 (-5.71%)

$210,368,000 (-5.15%)

$221,779,000 (64.81%)

$134,563,000 (22.70%)

Goodwill & Intangible Assets

$15,933,000 (-6.79%)

$17,093,000 (-14.55%)

$20,003,000 (1308.66%)

$1,420,000 (-2.94%)

Shareholders Equity

-$489,098,000 (16.68%)

-$586,987,000 (-31.22%)

-$447,327,000 (-84.71%)

-$242,173,000 (-102.13%)

Property Plant & Equipment Net

$170,457,000 (-6.66%)

$182,625,000 (-3.60%)

$189,447,000 (58.98%)

$119,167,000 (31.42%)

Cash & Equivalents

$143,428,000 (-45.97%)

$265,453,000 (153.68%)

$104,641,000 (-42.22%)

$181,101,000 (418.69%)

Accumulated Other Comprehensive Income

$1,198,000 (11880.00%)

$10,000 (-94.54%)

$183,000 (4475.00%)

$4,000 (-96.72%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$13,511,000 (53.90%)

$8,779,000 (-12.32%)

$10,012,000 (-93.32%)

$149,991,000 (90.65%)

Investments Current

$6,381,000 (532.41%)

$1,009,000 (-60.32%)

$2,543,000 (-98.13%)

$136,015,000 (122.44%)

Investments Non-Current

$7,130,000 (-8.24%)

$7,770,000 (4.03%)

$7,469,000 (-46.56%)

$13,976,000 (-20.26%)

Inventory

$8,272,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$2,653,000 (31.40%)

$2,019,000 (6.83%)

$1,890,000 (41.79%)

$1,333,000 (-33.45%)

Trade & Non-Trade Payables

$6,898,000 (-33.23%)

$10,331,000 (-57.81%)

$24,485,000 (59.40%)

$15,361,000 (-41.70%)

Accumulated Retained Earnings (Deficit)

-$3,375,248,000 (-13.96%)

-$2,961,684,000 (-24.52%)

-$2,378,488,000 (-21.23%)

-$1,961,921,000 (-21.47%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$788,570,000 (-10.61%)

$882,138,000 (21.88%)

$723,773,000 (12.10%)

$645,664,000 (134.32%)

Debt Current

$7,466,000 (42.37%)

$5,244,000 (-98.79%)

$434,551,000 (43.77%)

$302,247,000 (5926.86%)

Debt Non-Current

$781,104,000 (-10.92%)

$876,894,000 (203.19%)

$289,222,000 (-15.78%)

$343,417,000 (26.94%)

Total Liabilities

$871,062,000 (-20.11%)

$1,090,389,000 (34.26%)

$812,176,000 (13.94%)

$712,823,000 (109.73%)

Liabilities Current

$54,944,000 (-5.73%)

$58,283,000 (-88.36%)

$500,861,000 (35.74%)

$368,995,000 (441.57%)

Liabilities Non-Current

$816,118,000 (-20.93%)

$1,032,106,000 (231.53%)

$311,315,000 (-9.46%)

$343,828,000 (26.53%)

IBRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$14,745,000 (2270.58%)

$622,000 (159.17%)

$240,000 (-74.30%)

$934,000 (54.38%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$168,783,000 (30.21%)

$129,620,000 (26.20%)

$102,708,000 (-24.06%)

$135,256,000 (89.65%)

Research & Development Expense

$190,144,000 (-18.17%)

$232,366,000 (-6.36%)

$248,149,000 (26.63%)

$195,958,000 (40.46%)

Operating Expenses

$358,927,000 (-1.09%)

$362,872,000 (3.22%)

$351,538,000 (6.14%)

$331,214,000 (49.54%)

Interest Expense

$154,327,000 (19.45%)

$129,198,000 (103.41%)

$63,515,000 (327.74%)

$14,849,000 (63.64%)

Income Tax Expense

$0 (0%)

-$40,000 (-217.65%)

$34,000 (277.78%)

$9,000 (100.49%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$413,645,000 (29.15%)

-$583,852,000 (-39.91%)

-$417,320,000 (-19.29%)

-$349,848,000 (-56.05%)

Net Income to Non-Controlling Interests

-$81,000 (87.65%)

-$656,000 (12.88%)

-$753,000 (75.38%)

-$3,058,000 (-30.91%)

Net Income

-$413,564,000 (29.09%)

-$583,196,000 (-40.00%)

-$416,567,000 (-20.12%)

-$346,790,000 (-56.32%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$413,564,000 (29.09%)

-$583,196,000 (-40.00%)

-$416,567,000 (-20.12%)

-$346,790,000 (-56.32%)

Weighted Average Shares

$697,312,000 (37.09%)

$508,635,592 (27.19%)

$399,900,374 (2.74%)

$389,234,156 (3.23%)

Weighted Average Shares Diluted

$700,443,000 (37.71%)

$508,635,592 (27.19%)

$399,900,374 (2.74%)

$389,234,156 (3.23%)

Earning Before Interest & Taxes (EBIT)

-$259,237,000 (42.90%)

-$454,038,000 (-28.62%)

-$353,018,000 (-6.35%)

-$331,932,000 (-54.66%)

Gross Profit

$14,745,000 (2270.58%)

$622,000 (159.17%)

$240,000 (-74.30%)

$934,000 (54.38%)

Operating Income

-$344,182,000 (4.99%)

-$362,250,000 (-3.12%)

-$351,298,000 (-6.36%)

-$330,280,000 (-49.53%)

IBRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$12,246,000 (59.81%)

-$30,470,000 (-211.62%)

$27,297,000 (132.16%)

-$84,886,000 (-328.46%)

Net Cash Flow from Financing

$281,630,000 (-49.56%)

$558,341,000 (139.00%)

$233,613,000 (-53.78%)

$505,443,000 (235.45%)

Net Cash Flow from Operations

-$391,236,000 (-6.67%)

-$366,757,000 (-8.67%)

-$337,509,000 (-22.99%)

-$274,419,000 (-59.80%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$121,875,000 (-175.78%)

$160,822,000 (310.73%)

-$76,315,000 (-152.20%)

$146,186,000 (457.55%)

Net Cash Flow - Business Acquisitions and Disposals

-$1,000,000 (0%)

$0 (0%)

-$1,000,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$4,358,000 (-3922.81%)

$114,000 (-99.91%)

$127,688,000 (277.79%)

-$71,821,000 (-295.86%)

Capital Expenditure

-$6,888,000 (77.48%)

-$30,584,000 (60.87%)

-$78,162,000 (-498.25%)

-$13,065,000 (-682.80%)

Issuance (Repayment) of Debt Securities

-$64,000 (-100.02%)

$258,623,000 (48.58%)

$174,067,000 (-48.58%)

$338,500,000 (431.40%)

Issuance (Purchase) of Equity Shares

$179,888,000 (-39.98%)

$299,718,000 (400.49%)

$59,885,000 (-63.91%)

$165,927,000 (90.78%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$23,000 (92.12%)

-$292,000 (-202.82%)

$284,000 (491.67%)

$48,000 (292.00%)

Share Based Compensation

$34,432,000 (-29.96%)

$49,163,000 (22.36%)

$40,179,000 (-29.73%)

$57,181,000 (2514.59%)

Depreciation Amortization & Accretion

$23,310,000 (-5.34%)

$24,624,000 (1.79%)

$24,192,000 (26.51%)

$19,122,000 (6.86%)

IBRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-2804.80% (97.01%)

-93761.40% (45.98%)

-173569.60% (-367.47%)

-37129.60% (-1.25%)

EBITDA Margin

-1600.00% (97.68%)

-69037.60% (49.61%)

-137010.80% (-309.09%)

-33491.40% (-3.00%)

Return on Average Equity (ROAE)

63.00% (-41.40%)

107.50% (5.08%)

102.30% (-42.88%)

179.10% (160.75%)

Return on Average Assets (ROAA)

-103.90% (29.99%)

-148.40% (-26.73%)

-117.10% (3.86%)

-121.80% (0.49%)

Return on Sales (ROS)

-1758.10% (97.59%)

-72996.50% (50.37%)

-147090.80% (-313.89%)

-35538.80% (-0.18%)

Return on Invested Capital (ROIC)

-23.20% (64.47%)

-65.30% (-13.37%)

-57.60% (21.53%)

-73.40% (37.32%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.34 (0.60%)

-4.37 (10.46%)

-4.88 (28.63%)

-6.83 (69.76%)

Price to Sales Ratio (P/S)

121.07 (-97.05%)

4,105.06 (-51.41%)

8,447.89 (233.41%)

2,533.78 (-69.50%)

Price to Book Ratio (P/B)

-3.65 (36.13%)

-5.71 (-25.85%)

-4.54 (54.55%)

-9.98 (17.38%)

Debt to Equity Ratio (D/E)

-1.78 (4.14%)

-1.86 (-2.31%)

-1.82 (38.29%)

-2.94 (-3.74%)

Earnings Per Share (EPS)

-0.59 (48.70%)

-1.15 (-10.58%)

-1.04 (-16.85%)

-0.89 (-50.85%)

Sales Per Share (SPS)

0.02 (2000.00%)

0 (0.00%)

0 (-50.00%)

0 (0.00%)

Free Cash Flow Per Share (FCFPS)

-0.57 (26.89%)

-0.78 (24.83%)

-1.04 (-40.60%)

-0.74 (-60.65%)

Book Value Per Share (BVPS)

-0.7 (39.25%)

-1.15 (-3.13%)

-1.12 (-79.90%)

-0.62 (-95.60%)

Tangible Assets Book Value Per Share (TABVPS)

0.53 (-45.09%)

0.96 (11.92%)

0.86 (-28.73%)

1.2 (106.00%)

Enterprise Value Over EBIT (EV/EBIT)

-10 (-11.11%)

-9 (-28.57%)

-7 (12.50%)

-8 (-14.29%)

Enterprise Value Over EBITDA (EV/EBITDA)

-11.39 (-25.74%)

-9.06 (-12.98%)

-8.02 (6.86%)

-8.61 (-17.94%)

Asset Turnover

0.04 (1750.00%)

0 (100.00%)

0 (-66.67%)

0 (0.00%)

Current Ratio

3.36 (-33.41%)

5.05 (1695.73%)

0.28 (-68.98%)

0.91 (-44.76%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$398,124,000 (-0.20%)

-$397,341,000 (4.41%)

-$415,671,000 (-44.59%)

-$287,484,000 (-65.80%)

Enterprise Value (EV)

$2,688,491,118 (-30.91%)

$3,891,183,947 (47.54%)

$2,637,360,817 (-2.10%)

$2,693,804,773 (87.53%)

Earnings Before Tax (EBT)

-$413,564,000 (29.09%)

-$583,236,000 (-40.02%)

-$416,533,000 (-20.11%)

-$346,781,000 (-55.02%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$235,927,000 (45.06%)

-$429,414,000 (-30.59%)

-$328,826,000 (-5.12%)

-$312,810,000 (-59.01%)

Invested Capital

$957,198,000 (-8.47%)

$1,045,761,000 (127.03%)

$460,624,000 (-18.19%)

$563,058,000 (43.48%)

Working Capital

$129,642,000 (-45.02%)

$235,801,000 (165.45%)

-$360,284,000 (-939.84%)

-$34,648,000 (-179.51%)

Tangible Asset Value

$367,000,000 (-24.70%)

$487,359,000 (42.36%)

$342,353,000 (-26.77%)

$467,490,000 (112.57%)

Market Capitalization

$1,783,888,118 (-46.78%)

$3,351,880,947 (65.15%)

$2,029,541,817 (-16.04%)

$2,417,374,773 (67.00%)

Average Equity

-$656,161,250 (-20.96%)

-$542,450,750 (-33.16%)

-$407,371,250 (-110.42%)

-$193,599,250 (-357.22%)

Average Assets

$398,126,750 (1.34%)

$392,874,500 (10.47%)

$355,650,750 (24.89%)

$284,765,000 (57.09%)

Invested Capital Average

$1,119,004,250 (61.02%)

$694,955,500 (13.40%)

$612,854,500 (35.60%)

$451,945,250 (146.60%)

Shares

696,831,296 (4.36%)

667,705,368 (66.80%)

400,304,106 (0.68%)

397,594,535 (266.13%)